Copyright Reports & Markets. All rights reserved.

Global Plasmid Manufacture Market Growth (Status and Outlook) 2022-2028

Request for Sample of this report
Buy now

1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Plasmid Manufacture Market Size 2017-2028
    • 2.1.2 Plasmid Manufacture Market Size CAGR by Region 2017 VS 2022 VS 2028
  • 2.2 Plasmid Manufacture Segment by Type
    • 2.2.1 Preclinical Plasmid
    • 2.2.2 Clinical Plasmid
    • 2.2.3 Commercial Plasmid
  • 2.3 Plasmid Manufacture Market Size by Type
    • 2.3.1 Plasmid Manufacture Market Size CAGR by Type (2017 VS 2022 VS 2028)
    • 2.3.2 Global Plasmid Manufacture Market Size Market Share by Type (2017-2022)
  • 2.4 Plasmid Manufacture Segment by Application
    • 2.4.1 Commercial
    • 2.4.2 Academic Research
    • 2.4.3 Others
  • 2.5 Plasmid Manufacture Market Size by Application
    • 2.5.1 Plasmid Manufacture Market Size CAGR by Application (2017 VS 2022 VS 2028)
    • 2.5.2 Global Plasmid Manufacture Market Size Market Share by Application (2017-2022)

3 Plasmid Manufacture Market Size by Player

  • 3.1 Plasmid Manufacture Market Size Market Share by Players
    • 3.1.1 Global Plasmid Manufacture Revenue by Players (2020-2022)
    • 3.1.2 Global Plasmid Manufacture Revenue Market Share by Players (2020-2022)
  • 3.2 Global Plasmid Manufacture Key Players Head office and Products Offered
  • 3.3 Market Concentration Rate Analysis
    • 3.3.1 Competition Landscape Analysis
    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.4 New Products and Potential Entrants
  • 3.5 Mergers & Acquisitions, Expansion

4 Plasmid Manufacture by Regions

  • 4.1 Plasmid Manufacture Market Size by Regions (2017-2022)
  • 4.2 Americas Plasmid Manufacture Market Size Growth (2017-2022)
  • 4.3 APAC Plasmid Manufacture Market Size Growth (2017-2022)
  • 4.4 Europe Plasmid Manufacture Market Size Growth (2017-2022)
  • 4.5 Middle East & Africa Plasmid Manufacture Market Size Growth (2017-2022)

5 Americas

  • 5.1 Americas Plasmid Manufacture Market Size by Country (2017-2022)
  • 5.2 Americas Plasmid Manufacture Market Size by Type (2017-2022)
  • 5.3 Americas Plasmid Manufacture Market Size by Application (2017-2022)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Plasmid Manufacture Market Size by Region (2017-2022)
  • 6.2 APAC Plasmid Manufacture Market Size by Type (2017-2022)
  • 6.3 APAC Plasmid Manufacture Market Size by Application (2017-2022)
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia

7 Europe

  • 7.1 Europe Plasmid Manufacture by Country (2017-2022)
  • 7.2 Europe Plasmid Manufacture Market Size by Type (2017-2022)
  • 7.3 Europe Plasmid Manufacture Market Size by Application (2017-2022)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Plasmid Manufacture by Region (2017-2022)
  • 8.2 Middle East & Africa Plasmid Manufacture Market Size by Type (2017-2022)
  • 8.3 Middle East & Africa Plasmid Manufacture Market Size by Application (2017-2022)
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Global Plasmid Manufacture Market Forecast

  • 10.1 Global Plasmid Manufacture Forecast by Regions (2023-2028)
    • 10.1.1 Global Plasmid Manufacture Forecast by Regions (2023-2028)
    • 10.1.2 Americas Plasmid Manufacture Forecast
    • 10.1.3 APAC Plasmid Manufacture Forecast
    • 10.1.4 Europe Plasmid Manufacture Forecast
    • 10.1.5 Middle East & Africa Plasmid Manufacture Forecast
  • 10.2 Americas Plasmid Manufacture Forecast by Country (2023-2028)
    • 10.2.1 United States Plasmid Manufacture Market Forecast
    • 10.2.2 Canada Plasmid Manufacture Market Forecast
    • 10.2.3 Mexico Plasmid Manufacture Market Forecast
    • 10.2.4 Brazil Plasmid Manufacture Market Forecast
  • 10.3 APAC Plasmid Manufacture Forecast by Region (2023-2028)
    • 10.3.1 China Plasmid Manufacture Market Forecast
    • 10.3.2 Japan Plasmid Manufacture Market Forecast
    • 10.3.3 Korea Plasmid Manufacture Market Forecast
    • 10.3.4 Southeast Asia Plasmid Manufacture Market Forecast
    • 10.3.5 India Plasmid Manufacture Market Forecast
    • 10.3.6 Australia Plasmid Manufacture Market Forecast
  • 10.4 Europe Plasmid Manufacture Forecast by Country (2023-2028)
    • 10.4.1 Germany Plasmid Manufacture Market Forecast
    • 10.4.2 France Plasmid Manufacture Market Forecast
    • 10.4.3 UK Plasmid Manufacture Market Forecast
    • 10.4.4 Italy Plasmid Manufacture Market Forecast
    • 10.4.5 Russia Plasmid Manufacture Market Forecast
  • 10.5 Middle East & Africa Plasmid Manufacture Forecast by Region (2023-2028)
    • 10.5.1 Egypt Plasmid Manufacture Market Forecast
    • 10.5.2 South Africa Plasmid Manufacture Market Forecast
    • 10.5.3 Israel Plasmid Manufacture Market Forecast
    • 10.5.4 Turkey Plasmid Manufacture Market Forecast
    • 10.5.5 GCC Countries Plasmid Manufacture Market Forecast
  • 10.6 Global Plasmid Manufacture Forecast by Type (2023-2028)
  • 10.7 Global Plasmid Manufacture Forecast by Application (2023-2028)

11 Key Players Analysis

  • 11.1 Charles River
    • 11.1.1 Charles River Company Information
    • 11.1.2 Charles River Plasmid Manufacture Product Offered
    • 11.1.3 Charles River Plasmid Manufacture Revenue, Gross Margin and Market Share (2020-2022)
    • 11.1.4 Charles River Main Business Overview
    • 11.1.5 Charles River Latest Developments
  • 11.2 Lonza
    • 11.2.1 Lonza Company Information
    • 11.2.2 Lonza Plasmid Manufacture Product Offered
    • 11.2.3 Lonza Plasmid Manufacture Revenue, Gross Margin and Market Share (2020-2022)
    • 11.2.4 Lonza Main Business Overview
    • 11.2.5 Lonza Latest Developments
  • 11.3 Aldevron
    • 11.3.1 Aldevron Company Information
    • 11.3.2 Aldevron Plasmid Manufacture Product Offered
    • 11.3.3 Aldevron Plasmid Manufacture Revenue, Gross Margin and Market Share (2020-2022)
    • 11.3.4 Aldevron Main Business Overview
    • 11.3.5 Aldevron Latest Developments
  • 11.4 Thermo Fisher Scientific
    • 11.4.1 Thermo Fisher Scientific Company Information
    • 11.4.2 Thermo Fisher Scientific Plasmid Manufacture Product Offered
    • 11.4.3 Thermo Fisher Scientific Plasmid Manufacture Revenue, Gross Margin and Market Share (2020-2022)
    • 11.4.4 Thermo Fisher Scientific Main Business Overview
    • 11.4.5 Thermo Fisher Scientific Latest Developments
  • 11.5 Catalent
    • 11.5.1 Catalent Company Information
    • 11.5.2 Catalent Plasmid Manufacture Product Offered
    • 11.5.3 Catalent Plasmid Manufacture Revenue, Gross Margin and Market Share (2020-2022)
    • 11.5.4 Catalent Main Business Overview
    • 11.5.5 Catalent Latest Developments
  • 11.6 The Discovery Labs
    • 11.6.1 The Discovery Labs Company Information
    • 11.6.2 The Discovery Labs Plasmid Manufacture Product Offered
    • 11.6.3 The Discovery Labs Plasmid Manufacture Revenue, Gross Margin and Market Share (2020-2022)
    • 11.6.4 The Discovery Labs Main Business Overview
    • 11.6.5 The Discovery Labs Latest Developments
  • 11.7 BIOCENTRIQ
    • 11.7.1 BIOCENTRIQ Company Information
    • 11.7.2 BIOCENTRIQ Plasmid Manufacture Product Offered
    • 11.7.3 BIOCENTRIQ Plasmid Manufacture Revenue, Gross Margin and Market Share (2020-2022)
    • 11.7.4 BIOCENTRIQ Main Business Overview
    • 11.7.5 BIOCENTRIQ Latest Developments
  • 11.8 FUJIFILM Diosynth Biotechnologies
    • 11.8.1 FUJIFILM Diosynth Biotechnologies Company Information
    • 11.8.2 FUJIFILM Diosynth Biotechnologies Plasmid Manufacture Product Offered
    • 11.8.3 FUJIFILM Diosynth Biotechnologies Plasmid Manufacture Revenue, Gross Margin and Market Share (2020-2022)
    • 11.8.4 FUJIFILM Diosynth Biotechnologies Main Business Overview
    • 11.8.5 FUJIFILM Diosynth Biotechnologies Latest Developments
  • 11.9 Exothera
    • 11.9.1 Exothera Company Information
    • 11.9.2 Exothera Plasmid Manufacture Product Offered
    • 11.9.3 Exothera Plasmid Manufacture Revenue, Gross Margin and Market Share (2020-2022)
    • 11.9.4 Exothera Main Business Overview
    • 11.9.5 Exothera Latest Developments
  • 11.10 WuXi AppTec
    • 11.10.1 WuXi AppTec Company Information
    • 11.10.2 WuXi AppTec Plasmid Manufacture Product Offered
    • 11.10.3 WuXi AppTec Plasmid Manufacture Revenue, Gross Margin and Market Share (2020-2022)
    • 11.10.4 WuXi AppTec Main Business Overview
    • 11.10.5 WuXi AppTec Latest Developments
  • 11.11 Pharmaron
    • 11.11.1 Pharmaron Company Information
    • 11.11.2 Pharmaron Plasmid Manufacture Product Offered
    • 11.11.3 Pharmaron Plasmid Manufacture Revenue, Gross Margin and Market Share (2020-2022)
    • 11.11.4 Pharmaron Main Business Overview
    • 11.11.5 Pharmaron Latest Developments
  • 11.12 OBiO
    • 11.12.1 OBiO Company Information
    • 11.12.2 OBiO Plasmid Manufacture Product Offered
    • 11.12.3 OBiO Plasmid Manufacture Revenue, Gross Margin and Market Share (2020-2022)
    • 11.12.4 OBiO Main Business Overview
    • 11.12.5 OBiO Latest Developments
  • 11.13 Cell Therapies
    • 11.13.1 Cell Therapies Company Information
    • 11.13.2 Cell Therapies Plasmid Manufacture Product Offered
    • 11.13.3 Cell Therapies Plasmid Manufacture Revenue, Gross Margin and Market Share (2020-2022)
    • 11.13.4 Cell Therapies Main Business Overview
    • 11.13.5 Cell Therapies Latest Developments
  • 11.14 AGC Biologics
    • 11.14.1 AGC Biologics Company Information
    • 11.14.2 AGC Biologics Plasmid Manufacture Product Offered
    • 11.14.3 AGC Biologics Plasmid Manufacture Revenue, Gross Margin and Market Share (2020-2022)
    • 11.14.4 AGC Biologics Main Business Overview
    • 11.14.5 AGC Biologics Latest Developments
  • 11.15 Cytiva
    • 11.15.1 Cytiva Company Information
    • 11.15.2 Cytiva Plasmid Manufacture Product Offered
    • 11.15.3 Cytiva Plasmid Manufacture Revenue, Gross Margin and Market Share (2020-2022)
    • 11.15.4 Cytiva Main Business Overview
    • 11.15.5 Cytiva Latest Developments
  • 11.16 Helixmith
    • 11.16.1 Helixmith Company Information
    • 11.16.2 Helixmith Plasmid Manufacture Product Offered
    • 11.16.3 Helixmith Plasmid Manufacture Revenue, Gross Margin and Market Share (2020-2022)
    • 11.16.4 Helixmith Main Business Overview
    • 11.16.5 Helixmith Latest Developments
  • 11.17 ThermoGenesis
    • 11.17.1 ThermoGenesis Company Information
    • 11.17.2 ThermoGenesis Plasmid Manufacture Product Offered
    • 11.17.3 ThermoGenesis Plasmid Manufacture Revenue, Gross Margin and Market Share (2020-2022)
    • 11.17.4 ThermoGenesis Main Business Overview
    • 11.17.5 ThermoGenesis Latest Developments
  • 11.18 Anemocyte
    • 11.18.1 Anemocyte Company Information
    • 11.18.2 Anemocyte Plasmid Manufacture Product Offered
    • 11.18.3 Anemocyte Plasmid Manufacture Revenue, Gross Margin and Market Share (2020-2022)
    • 11.18.4 Anemocyte Main Business Overview
    • 11.18.5 Anemocyte Latest Developments
  • 11.19 CBM
    • 11.19.1 CBM Company Information
    • 11.19.2 CBM Plasmid Manufacture Product Offered
    • 11.19.3 CBM Plasmid Manufacture Revenue, Gross Margin and Market Share (2020-2022)
    • 11.19.4 CBM Main Business Overview
    • 11.19.5 CBM Latest Developments
  • 11.20 Bio Elpida
    • 11.20.1 Bio Elpida Company Information
    • 11.20.2 Bio Elpida Plasmid Manufacture Product Offered
    • 11.20.3 Bio Elpida Plasmid Manufacture Revenue, Gross Margin and Market Share (2020-2022)
    • 11.20.4 Bio Elpida Main Business Overview
    • 11.20.5 Bio Elpida Latest Developments
  • 11.21 Genezen
    • 11.21.1 Genezen Company Information
    • 11.21.2 Genezen Plasmid Manufacture Product Offered
    • 11.21.3 Genezen Plasmid Manufacture Revenue, Gross Margin and Market Share (2020-2022)
    • 11.21.4 Genezen Main Business Overview
    • 11.21.5 Genezen Latest Developments
  • 11.22 CCRM
    • 11.22.1 CCRM Company Information
    • 11.22.2 CCRM Plasmid Manufacture Product Offered
    • 11.22.3 CCRM Plasmid Manufacture Revenue, Gross Margin and Market Share (2020-2022)
    • 11.22.4 CCRM Main Business Overview
    • 11.22.5 CCRM Latest Developments
  • 11.23 RoslinCT
    • 11.23.1 RoslinCT Company Information
    • 11.23.2 RoslinCT Plasmid Manufacture Product Offered
    • 11.23.3 RoslinCT Plasmid Manufacture Revenue, Gross Margin and Market Share (2020-2022)
    • 11.23.4 RoslinCT Main Business Overview
    • 11.23.5 RoslinCT Latest Developments
  • 11.24 GenScript ProBio
    • 11.24.1 GenScript ProBio Company Information
    • 11.24.2 GenScript ProBio Plasmid Manufacture Product Offered
    • 11.24.3 GenScript ProBio Plasmid Manufacture Revenue, Gross Margin and Market Share (2020-2022)
    • 11.24.4 GenScript ProBio Main Business Overview
    • 11.24.5 GenScript ProBio Latest Developments
  • 11.25 Oxford BioMedica
    • 11.25.1 Oxford BioMedica Company Information
    • 11.25.2 Oxford BioMedica Plasmid Manufacture Product Offered
    • 11.25.3 Oxford BioMedica Plasmid Manufacture Revenue, Gross Margin and Market Share (2020-2022)
    • 11.25.4 Oxford BioMedica Main Business Overview
    • 11.25.5 Oxford BioMedica Latest Developments
  • 11.26 Porton Pharma Solutions
    • 11.26.1 Porton Pharma Solutions Company Information
    • 11.26.2 Porton Pharma Solutions Plasmid Manufacture Product Offered
    • 11.26.3 Porton Pharma Solutions Plasmid Manufacture Revenue, Gross Margin and Market Share (2020-2022)
    • 11.26.4 Porton Pharma Solutions Main Business Overview
    • 11.26.5 Porton Pharma Solutions Latest Developments

12 Research Findings and Conclusion

The global market for Plasmid Manufacture is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

The APAC Plasmid Manufacture market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The United States Plasmid Manufacture market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The Europe Plasmid Manufacture market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The China Plasmid Manufacture market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

Global key Plasmid Manufacture players cover Charles River, Lonza, Aldevron, Thermo Fisher Scientific and Catalent, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

Report Coverage
This latest report provides a deep insight into the global Plasmid Manufacture market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.

This report aims to provide a comprehensive picture of the global Plasmid Manufacture market, with both quantitative and qualitative data, to help readers understand how the Plasmid Manufacture market scenario changed across the globe during the pandemic and Russia-Ukraine War.

The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.

Market Segmentation:
The study segments the Plasmid Manufacture market and forecasts the market size by Type (Preclinical Plasmid, Clinical Plasmid and Commercial Plasmid), by Application (Commercial, Academic Research and Others,), and region (APAC, Americas, Europe, and Middle East & Africa).

Segmentation by type
Preclinical Plasmid
Clinical Plasmid
Commercial Plasmid

Segmentation by application
Commercial
Academic Research
Others

Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Major companies covered
Charles River
Lonza
Aldevron
Thermo Fisher Scientific
Catalent
The Discovery Labs
BIOCENTRIQ
FUJIFILM Diosynth Biotechnologies
Exothera
WuXi AppTec
Pharmaron
OBiO
Cell Therapies
AGC Biologics
Cytiva
Helixmith
ThermoGenesis
Anemocyte
CBM
Bio Elpida
Genezen
CCRM
RoslinCT
GenScript ProBio
Oxford BioMedica
Porton Pharma Solutions

Chapter Introduction
Chapter 1: Scope of Plasmid Manufacture, Research Methodology, etc.
Chapter 2: Executive Summary, global Plasmid Manufacture market size and CAGR, Plasmid Manufacture market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Plasmid Manufacture revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Plasmid Manufacture revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Plasmid Manufacture market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Charles River, Lonza, Aldevron, Thermo Fisher Scientific, Catalent, The Discovery Labs, BIOCENTRIQ, FUJIFILM Diosynth Biotechnologies and Exothera, etc.
Chapter 14: Research Findings and Conclusion
Buy now